1995
DOI: 10.1016/0005-2760(95)00146-4
|View full text |Cite
|
Sign up to set email alerts
|

Molecular mechanisms of diverse actions of prostanoid receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
246
2
1

Year Published

1996
1996
2015
2015

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 370 publications
(259 citation statements)
references
References 72 publications
10
246
2
1
Order By: Relevance
“…The molecular mechanisms by which the low concentration of LTB 4 exerts anti-catabolic action against PGE 2 and the potential molecular interplay between PGE 2 and LTB 4 will be of special interest and future studies are required. In addition, it is known that LTB 4 and PGE 2 actions are mediated via their receptors, e.g., BLT1 and BLT2 (Tager and Luster, 2003) and EP1, EP2, EP3, and EP4 (Negishi et al, 1995;Narumiya et al, 1999), respectively. Thus, it is important to investigate the expression and/or activation of their cognate receptors and the signaling pathways for better understanding the precise role of dosedependent counter-activity of LTB 4 on PGE 2 in tendon homeostasis in future studies.…”
Section: Discussionmentioning
confidence: 99%
“…The molecular mechanisms by which the low concentration of LTB 4 exerts anti-catabolic action against PGE 2 and the potential molecular interplay between PGE 2 and LTB 4 will be of special interest and future studies are required. In addition, it is known that LTB 4 and PGE 2 actions are mediated via their receptors, e.g., BLT1 and BLT2 (Tager and Luster, 2003) and EP1, EP2, EP3, and EP4 (Negishi et al, 1995;Narumiya et al, 1999), respectively. Thus, it is important to investigate the expression and/or activation of their cognate receptors and the signaling pathways for better understanding the precise role of dosedependent counter-activity of LTB 4 on PGE 2 in tendon homeostasis in future studies.…”
Section: Discussionmentioning
confidence: 99%
“…Prostaglandin E2 (PGE2) produces a broad range of biological actions in diverse tissues through its binding to specific receptors on plasma membranes [1]. PGE receptors are pharmacologically subdivided into four subtypes, EP1, EP2, EP3, and EP4, on the basis of their responses to various agonists and antagonists [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…TXA 2 is a potent stimulator of platelet aggregation and smooth muscle contraction and may play a role as a mediator of myocardial infarction, atherosclerosis, and bronchial asthma (22). Increased activity of TXA 2 has also been implicated in several forms of human and experimental pulmonary hypertension, including pulmonary hypertension induced by sepsis (36), heparin/protamine (19), and ischemia-reperfusion (39).…”
mentioning
confidence: 99%